# Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification

> **NCT01631669** · NA · UNKNOWN · sponsor: **Walter Reed National Military Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Ossification, Heterotopic

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT01631669
- **Lead sponsor:** Walter Reed National Military Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2015-06
- **Final completion:** 2018-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01631669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01631669, "Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic Ossification". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01631669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*